Benzinga Rankings give you vital metrics on any stock – anytime.
Explore ITeos Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ITOS.
You can purchase shares of ITeos Therapeutics (NASDAQ:ITOS) through any online brokerage.
Other companies in ITeos Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), aTyr Pharma (NASDAQ:ATYR), Monte Rosa Therapeutics (NASDAQ:GLUE), Abeona Therapeutics (NASDAQ:ABEO) and Emergent BioSolutions (NYSE:EBS).
ITeos Therapeutics has a consensus price target of $33.17.
The stock price for ITeos Therapeutics (NASDAQ: ITOS) is $7.46 last updated April 24, 2025 at 4:00 PM EDT.
There are no upcoming dividends for ITeos Therapeutics.
ITeos Therapeutics’s Q1 earnings are confirmed for Friday, May 9, 2025.
There is no upcoming split for ITeos Therapeutics.
ITeos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.